Thank you, Mr. Chair.
When an organization responsible for promoting a reform and holding consultations plans to discredit the stakeholders and the people involved in the consultation, I think that things are starting badly and could end up worse. As I read all of the submissions, I see points of convergence that stand out, and that is what we should focus on today.
For those who are concerned about conflict of interest, there is an organization called Research Canada, which represents academic health science centres, universities, colleges, associations of research societies, charities, networks of centres of excellence, organizations in the biopharmaceutical sector, in short, a number of “institutional people”, if I can put it that way, who have the same concerns as you, Ms. Perrault.
The organization states: “In essence, the federal government is flying blind into the implementation of its PMPRB reforms...” That's on page 2 of the brief, for people who are going to ask me where I got it. It comes to the conclusion: “in the absence of an inclusive consultation that not just the guidelines..., but the PMPRB reforms as a whole, may prove unaffordable for our economy, our health system and our most vulnerable patients.”
What do you think?